This page is part of the HL7 Europe Laboratory Report (v0.1.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "Observation",
"id" : "obs-org-id1-susc-2",
"meta" : {
"profile" : [
🔗 "http://hl7.eu/fhir/laboratory/StructureDefinition/Observation-resultslab-eu-lab"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Observation</b><a name=\"obs-org-id1-susc-2\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Observation "obs-org-id1-susc-2" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Observation-resultslab-eu-lab.html\">Observation Results: laboratory</a></p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-observation-category.html\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: levoFLOXacin [Susceptibility] <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#20629-2)</span></p><p><b>subject</b>: <a href=\"Patient-pat-lab-example.html\">Patient/pat-lab-example</a> " OČKOVANÝ MOREIRA"</p><p><b>effective</b>: 2022-10-25 13:35:00+0100</p><p><b>performer</b>: <span>: MUDr. Aleš Procházka</span></p><p><b>value</b>: >4 1<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code 1 = '1')</span></p><p><b>interpretation</b>: Resistant <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#R)</span></p></div>"
},
"status" : "final",
"category" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/observation-category",
"code" : "laboratory"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "20629-2",
"display" : "levoFLOXacin [Susceptibility]"
}
]
},
"subject" : {
🔗 "reference" : "Patient/pat-lab-example"
},
"effectiveDateTime" : "2022-10-25T13:35:00+01:00",
"performer" : [
{
"display" : "MUDr. Aleš Procházka"
}
],
"valueQuantity" : {
"value" : 4,
"comparator" : ">",
"system" : "http://unitsofmeasure.org",
"code" : "1"
},
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "R",
"display" : "Resistant"
}
]
}
]
}